Vaginal fetal fibronectin evaluation before and immediately after ultrasonographic vaginal cervical length measurements in symptomatic women at risk of preterm birth: A pilot study

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue 8, 2010, Pages 854-856

  Ben Haroush, Avi ^a,b   Poran, Eran ^a,b   Yogev, Yariv ^a,b   Glezerman, Marek ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cervical length; fetal fibronectin; vaginal ultrasound

Indexed keywords

FIBRONECTIN; FFN PROTEIN, HUMAN;

ARTICLE; CERVICAL LENGTH MEASUREMENT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; GESTATION PERIOD; HIGH RISK PREGNANCY; HUMAN; PILOT STUDY; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN SECRETION; TRANSVAGINAL ECHOGRAPHY; ECHOGRAPHY; LABORATORY DIAGNOSIS; METABOLISM; PREGNANCY; PREMATURITY; VAGINA;

CERVICAL LENGTH MEASUREMENT; FALSE POSITIVE REACTIONS; FEMALE; FIBRONECTINS; HUMANS; PILOT PROJECTS; PREGNANCY; PREMATURE BIRTH; VAGINA;

EID: 77954721987     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767050903300977     Document Type: Article

References (7)

1. Kiefer DG, Vintzileos AM. The utility of fetal fibronectin in the prediction and prevention of spontaneous preterm birth. Rev Obstet Gynecol 2008;1:106-112.
2. Gomez R, Romero R, Medina L, Nien JK, Chaiworapongsa T, Carstens M, González R, Espinoza J, Iams JD, Edwin S, et al. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Am J Obstet Gynecol 2005;192:350-359.
3. Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D. The Preterm Prediction Study: fetal fibronectin testing and spontaneous preterm birth. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol 1996;87:643-648.
4. Matsuura H, Hakomori SI. The oncofetal domain of fibronectin defined by the monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Natl Acad Sci USA 1985;82:6517-6521.
5. Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, Jones L, Deligdisch L, Garite TJ. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325:669-674.
6. Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, Thom E, McNellis E, Copper RL, Johnson F, et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med 1996;334:567-572.
7. Goldenberg RL, Iams JD, Das A, Mercer BM, Meis PJ, Moawad AH, Miodovnik M, VanDorsten JP, Caritis SN, Thurnau GR, et al. The Preterm Prediction Study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2000;182:636-643. (Pubitemid 30207325)